JP2020502126A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502126A5
JP2020502126A5 JP2019531761A JP2019531761A JP2020502126A5 JP 2020502126 A5 JP2020502126 A5 JP 2020502126A5 JP 2019531761 A JP2019531761 A JP 2019531761A JP 2019531761 A JP2019531761 A JP 2019531761A JP 2020502126 A5 JP2020502126 A5 JP 2020502126A5
Authority
JP
Japan
Prior art keywords
ingestible device
ingestible
jak inhibitor
cecum
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019531761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020502126A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/066492 external-priority patent/WO2018112245A1/en
Publication of JP2020502126A publication Critical patent/JP2020502126A/ja
Publication of JP2020502126A5 publication Critical patent/JP2020502126A5/ja
Priority to JP2023000128A priority Critical patent/JP2023052188A/ja
Pending legal-status Critical Current

Links

JP2019531761A 2016-12-14 2017-12-14 消化管疾病のjak阻害薬による治療 Pending JP2020502126A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023000128A JP2023052188A (ja) 2016-12-14 2023-01-04 消化管疾病のjak阻害薬による治療

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201662434374P 2016-12-14 2016-12-14
US62/434,374 2016-12-14
US201762478919P 2017-03-30 2017-03-30
US62/478,919 2017-03-30
US201762545380P 2017-08-14 2017-08-14
US62/545,380 2017-08-14
US201762583832P 2017-11-09 2017-11-09
US62/583,832 2017-11-09
PCT/US2017/066492 WO2018112245A1 (en) 2016-12-14 2017-12-14 Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023000128A Division JP2023052188A (ja) 2016-12-14 2023-01-04 消化管疾病のjak阻害薬による治療

Publications (2)

Publication Number Publication Date
JP2020502126A JP2020502126A (ja) 2020-01-23
JP2020502126A5 true JP2020502126A5 (enExample) 2021-01-28

Family

ID=60953958

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019531761A Pending JP2020502126A (ja) 2016-12-14 2017-12-14 消化管疾病のjak阻害薬による治療
JP2023000128A Pending JP2023052188A (ja) 2016-12-14 2023-01-04 消化管疾病のjak阻害薬による治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023000128A Pending JP2023052188A (ja) 2016-12-14 2023-01-04 消化管疾病のjak阻害薬による治療

Country Status (10)

Country Link
US (3) US11033490B2 (enExample)
EP (2) EP4190318A1 (enExample)
JP (2) JP2020502126A (enExample)
KR (1) KR20190097107A (enExample)
CN (2) CN110072519A (enExample)
AU (2) AU2017378398B2 (enExample)
BR (1) BR112019012062A2 (enExample)
CA (1) CA3045666A1 (enExample)
MX (1) MX2019006821A (enExample)
WO (1) WO2018112245A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4190318A1 (en) * 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
WO2018165581A1 (en) * 2017-03-09 2018-09-13 Abbvie Inc. Methods of treating crohn's disease and ulcerative colitis
US11564922B2 (en) 2017-03-09 2023-01-31 Abbvie Inc. Methods of treating crohn's disease and ulcerative colitis
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
IL301683B2 (en) 2017-05-17 2025-02-01 Massachusetts Inst Technology Self-healing systems and related components and methods
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
US12171764B2 (en) * 2018-06-20 2024-12-24 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
MX2021007260A (es) 2018-12-19 2021-09-08 Incyte Corp Inhibidores de la vía de cinasa janus 1 (jak1) para el tratamiento de enfermedades gastrointestinales.
US11771829B2 (en) 2019-02-01 2023-10-03 Massachusetts Institute Of Technology Systems and methods for liquid injection
CN112393827A (zh) * 2019-08-12 2021-02-23 南京理工大学 一种可生物降解的压电力传感器的制备方法
CN112578123B (zh) * 2019-09-27 2022-10-25 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
WO2021174024A1 (en) 2020-02-28 2021-09-02 First Wave Bio, Inc. Methods of treating iatrogenic autoimmune colitis
US11471442B2 (en) * 2020-05-14 2022-10-18 Theravance Biopharma R&D Ip, Llc Administration of gut-selective JAK3 inhibitor
CN111920812B (zh) * 2020-07-10 2022-09-20 深圳市臻质医疗科技有限公司 一种钙通道抑制剂氧海罂粟碱在骨关节炎中的应用
CN113081075B (zh) * 2021-03-09 2022-03-04 武汉大学 一种具有主动式活检与施药功能的磁控胶囊
KR20230162959A (ko) * 2021-03-31 2023-11-29 쿨리아 랩스, 인크. 휴대용 초분광 시스템
CN118986930B (zh) * 2024-08-06 2025-04-04 海南医科大学(海南省医学科学院) 一种鲁索替尼固体脂质纳米粒及其制备方法
CN119226940B (zh) * 2024-12-05 2025-03-04 四川省医学科学院·四川省人民医院 一种基于brs加速度的肠道运动智能识别方法及系统

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IL47062A (en) 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4281645A (en) 1977-06-28 1981-08-04 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs
US4190328A (en) 1978-12-01 1980-02-26 Levine Robert A Process for detection of blood-borne parasites
JPS5588732A (en) 1978-12-26 1980-07-04 Olympus Optical Co Endoscope
US4665077A (en) 1979-03-19 1987-05-12 The Upjohn Company Method for treating rejection of organ or skin grafts with 6-aryl pyrimidine compounds
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
IL85746A (en) 1988-03-15 1994-05-30 Yeda Res & Dev Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases
FI891226A7 (fi) 1988-04-28 1989-10-29 The Board Of Trustees Of The Leland Anti-T-solun reseptorideterminantit autoimmuunisairauden hoitoon
JP2681061B2 (ja) 1988-06-08 1997-11-19 ロンドン・ダイアグノスティック・インコーポレーテッド 検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ
WO1990008187A1 (en) 1989-01-19 1990-07-26 Dana Farber Cancer Institute Soluble two domain cd2 protein
CA2046909A1 (en) 1989-03-21 1990-09-22 Mark D. Howell Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
AU652540B2 (en) 1989-07-19 1994-09-01 Xoma Corporation T cell receptor peptides as therapeutics for autoimmune and malignant disease
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5279607A (en) * 1991-05-30 1994-01-18 The State University Of New York Telemetry capsule and process
US5314805A (en) 1991-10-28 1994-05-24 Molecular Probes, Inc. Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM
US5318557A (en) 1992-07-13 1994-06-07 Elan Medical Technologies Limited Medication administering device
EP0656946B2 (en) 1992-08-21 2010-03-31 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US5763602A (en) 1996-10-01 1998-06-09 Li; Ying-Syi Methods of syntheses of phthalocyanine compounds
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AU2679899A (en) 1998-02-18 1999-09-06 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
US6331530B1 (en) 1999-07-13 2001-12-18 The Trustees Of Columbia University In The City Of New York Hydrophilic carrier for photosensitizers that cleaves when they catalyze the formation of singlet oxygen
US6703248B1 (en) 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
GB9930000D0 (en) * 1999-12-21 2000-02-09 Phaeton Research Ltd An ingestible device
US20030117491A1 (en) 2001-07-26 2003-06-26 Dov Avni Apparatus and method for controlling illumination in an in-vivo imaging device
KR20040108655A (ko) 2002-03-05 2004-12-24 아클라라 바이오사이언시스 인코퍼레이티드 막-결합된 민감제를 사용하는 복합 분석법
US7797033B2 (en) 2002-04-08 2010-09-14 Smart Pill Corporation Method of using, and determining location of, an ingestible capsule
CA2491355A1 (en) 2002-07-05 2004-01-15 Temrel Limited Controlled release compositions comprising coated pellets having non-uniform coating thicknesses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
RU2334506C2 (ru) 2003-01-29 2008-09-27 И-Пилл Фарма Лтд. Активная доставка лекарственного средства в желудочно-кишечном тракте
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
EP1643906A2 (en) 2003-06-12 2006-04-12 University of Utah Research Foundation Apparatus, systems and methods for diagnosing carpal tunnel syndrome
US7402398B2 (en) 2003-07-17 2008-07-22 Monogram Biosciences, Inc. Measuring receptor homodimerization
JP4445732B2 (ja) 2003-08-29 2010-04-07 オリンパス株式会社 被検体内導入装置および無線型被検体内情報取得システム
US20050065441A1 (en) 2003-08-29 2005-03-24 Arkady Glukhovsky System, apparatus and method for measurement of motion parameters of an in-vivo device
JP2005074031A (ja) 2003-09-01 2005-03-24 Pentax Corp カプセル内視鏡
CN1874789A (zh) 2003-09-23 2006-12-06 光科学公司 用于光动力疗法的缀合物
US8206285B2 (en) 2003-12-31 2012-06-26 Given Imaging Ltd. Apparatus, system and method to indicate in-vivo device location
BRPI0509271A (pt) * 2004-03-26 2007-09-04 Lek Pharmaceuticals formas de dosagens farmacêuticas gastrorresistentes compreendendo ácido n-(2-(2-ftalimidaetóxi)-acetil-l-alanil-d-glutámico(lk-4 23)
US7970455B2 (en) * 2004-05-20 2011-06-28 Spectrum Dynamics Llc Ingestible device platform for the colon
WO2005113374A2 (en) 2004-05-21 2005-12-01 Given Imaging Ltd. Device, system and method for in-vivo sampling
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
EP1841490A2 (en) * 2005-01-18 2007-10-10 Koninklijke Philips Electronics N.V. Electronically controlled capsule
ES2424042T3 (es) 2005-06-07 2013-09-26 Esbatech - A Novartis Company Llc Anticuerpos estables y solubles que inhiben TNF±
US20070027362A1 (en) 2005-07-27 2007-02-01 Olympus Medical Systems Corp. Infrared observation system
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
TWI323734B (en) 2005-08-19 2010-04-21 Abbott Lab Dual variable domain immunoglobulin and uses thereof
US8338416B2 (en) * 2006-03-16 2012-12-25 Pharmacylics, Inc. Indole derivatives as inhibitors of histone deacetylase
US20080112885A1 (en) 2006-09-06 2008-05-15 Innurvation, Inc. System and Method for Acoustic Data Transmission
RU2009120512A (ru) * 2006-10-31 2010-12-10 Конинклейке Филипс Электроникс Н.В. (Nl) Конструкция глотаемого дозирующего устройства с множеством форсунок для выпуска лекарств в желудочно-кишечный тракт
EP2125076B1 (en) 2007-02-26 2012-06-20 Duocure, Inc. Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
JP4932588B2 (ja) 2007-05-08 2012-05-16 オリンパス株式会社 画像処理装置および画像処理プログラム
EP2725035A1 (en) 2007-10-02 2014-04-30 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
EP2254464B1 (en) 2008-02-18 2017-01-04 Medimetrics Personalized Drug Delivery B.V. Administration of drugs to a patient
KR100931946B1 (ko) 2009-06-10 2009-12-15 주식회사 인트로메딕 캡슐 내시경에 의해 촬영된 이미지 데이터를 저장하고 있는 서버로부터 관심있는 데이터를 우선하여 단말기에 수신하여 확인할 수 있도록 하는 서버-클라이언트 시스템의 이미지 데이터 전송 프로세싱 방법
WO2011004395A1 (en) 2009-07-06 2011-01-13 Intas Biopharmaceuticals Limited Microemulsion formulation for biologicals
JP6030956B2 (ja) 2009-08-05 2016-11-24 テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド 胃腸管の異常の診断に使える情報を提供する方法と機器
US9026192B2 (en) 2009-11-24 2015-05-05 Given Imaging Ltd Device and method for in vivo imaging
WO2011069141A2 (en) 2009-12-04 2011-06-09 Board Of Regents, The University Of Texas System Interferon therapies in combination with blockade of stat3 activation
EP2571573A4 (en) 2010-03-17 2013-12-04 Photopill Medical Ltd PHOTOTHERAPY BY CAPSULE
US20130143915A1 (en) 2010-07-01 2013-06-06 Cellzome Limited Triazolopyridines as tyk2 inhibitors
CA2817785A1 (en) 2010-11-19 2012-05-24 Toby Blench Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
WO2012137705A1 (ja) 2011-04-01 2012-10-11 オリンパスメディカルシステムズ株式会社 受信装置及びカプセル型内視鏡システム
US9527925B2 (en) * 2011-04-01 2016-12-27 Boehringer Ingelheim International Gmbh Bispecific binding molecules binding to VEGF and ANG2
US20140228715A1 (en) * 2011-05-13 2014-08-14 The General Hospital Corporation Method and Apparatus for Delivering a Substance
US8907081B2 (en) 2011-05-27 2014-12-09 Sharp Laboratories Of America, Inc. Long wavelength absorbing porphyrin photosensitizers for dye-sensitized solar cells
EP2554544A1 (en) * 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
WO2013080050A2 (en) 2011-11-30 2013-06-06 Universitaetsklinikum Erlangen Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
WO2013088444A2 (en) 2011-12-15 2013-06-20 Given Imaging Ltd. Device, system and method for in-vivo detection of bleeding in the gastrointestinal tract
US9795330B2 (en) 2011-12-15 2017-10-24 Given Imaging Ltd. Device, system and method for in-vivo detection of bleeding in the gastrointestinal tract
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
FR2986432B1 (fr) 2012-02-06 2014-03-14 Univ Lille Ii Droit & Sante Proteines 28kda gst provenant de schistosomes pour leur utilisation dans le traitement des maladies inflammatoires auto-immunes engendrant une reponse de type th1 et/ou th17
EP2819584B1 (en) 2012-02-17 2020-04-08 Progenity, Inc. Ingestible medical device
DK3040336T3 (da) 2012-03-02 2020-06-22 Sareum Ltd Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
CA2875990A1 (en) 2012-05-24 2013-11-28 Cellzome Limited Heterocyclyl pyrimidine analogues as tyk2 inhibitors
SMT202500302T1 (it) 2012-06-15 2025-09-12 Sun Pharmaceutical Industries Inc Derivati deuterati del ruxolitinib
EP3949953A1 (en) * 2012-11-15 2022-02-09 Incyte Holdings Corporation Sustained-release dosage forms of ruxolitinib
TWI527811B (zh) * 2013-05-09 2016-04-01 吉李德科學股份有限公司 作爲溴結構域抑制劑的苯並咪唑衍生物
RU2015155552A (ru) 2013-05-24 2017-06-27 Нестек С.А. Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника
JP2016528174A (ja) * 2013-05-31 2016-09-15 セルリアン・ファーマ・インコーポレイテッド 治療的送達用のシクロデキストリンベースのポリマー
US9324145B1 (en) 2013-08-08 2016-04-26 Given Imaging Ltd. System and method for detection of transitions in an image stream of the gastrointestinal tract
WO2015059569A1 (en) 2013-09-26 2015-04-30 Medimetrics Personalized Drug Delivery, B.V. Delivery capsule with threshold release
EP3060234A1 (en) 2013-10-24 2016-08-31 AbbVie Inc. Jak1 selective inhibitor and uses thereof
US20160249793A1 (en) 2013-12-27 2016-09-01 Kang-Huai Wang Capsule Camera Device with Multi-Spectral Light Sources
ES2923641T3 (es) 2013-12-30 2022-09-29 Epimab Biotherapeutics Inc Inmunoglobulina con Fabs en tándem y usos de la misma
US10219748B2 (en) 2014-01-22 2019-03-05 Nutech Ventures Gastrointestinal sensor implantation system
US10281017B2 (en) 2014-05-30 2019-05-07 Schaeffler Technologies AG & Co. KG Torque converter including spherical clutch
CA2955666A1 (en) * 2014-08-13 2016-02-18 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
AU2015319850B2 (en) 2014-09-25 2019-09-26 Bt Bidco, Inc. Electromechanical pill device with localization capabilities
US9714288B2 (en) 2014-09-30 2017-07-25 The Regents Of The University Of California Antisense compounds and uses thereof
CN104473611B (zh) 2015-01-19 2018-01-30 吉林大学 具有超声波定位功能的胶囊内窥镜系统
CN105877685B (zh) * 2015-01-26 2019-03-15 香港中文大学 内窥镜胶囊和内窥镜系统
TWI744225B (zh) 2015-02-27 2021-11-01 美商林伯士拉克許米公司 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途
KR20170122776A (ko) * 2015-03-06 2017-11-06 신세틱 바이오로직스, 인코퍼레이티드 마이크로바이옴 보호를 위한 안전하고 유효한 베타-락타마제 투약
WO2016193964A1 (en) * 2015-05-31 2016-12-08 Check-Cap Ltd. Drug delivery capsule
JP2017012395A (ja) 2015-06-30 2017-01-19 富士フイルム株式会社 内視鏡システム及び内視鏡システムの作動方法
CA3034267A1 (en) 2016-08-18 2018-02-22 Mitchell Lawrence Jones Systems for obtaining samples using ingestible devices
CA3036334A1 (en) 2016-09-09 2018-03-15 Mitchell Lawrence Jones Systems and methods for extracting a sample from an ingestible device
US20180070857A1 (en) 2016-09-09 2018-03-15 Progenity Inc. Electromechanical ingestible device for delivery of a dispensable substance
EP3551047A1 (en) 2016-12-07 2019-10-16 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
CA3047241A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Ingestible device recovery system
EP4190318A1 (en) * 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
WO2018112425A1 (en) 2016-12-15 2018-06-21 Progenity Inc. Ingestible device and associated methods
EP3900613B1 (en) 2017-03-31 2023-12-27 Biora Therapeutics, Inc. Localization methods for an ingestible device
US12171764B2 (en) * 2018-06-20 2024-12-24 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
WO2023091991A1 (en) 2021-11-17 2023-05-25 H2 Clipper, Inc. Improved system, method and apparatus for airship manufacture using robotics

Similar Documents

Publication Publication Date Title
JP2020502126A5 (enExample)
JP2020502125A5 (enExample)
JP2020501699A5 (enExample)
JP2020513414A5 (enExample)
JP2020515579A5 (enExample)
JP2021098727A5 (enExample)
AR084610A1 (es) Comprimido de desintegracion oral de lansoprazol
Ibekwe et al. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery
JP2019526423A5 (enExample)
JP2010047612A5 (enExample)
AR078499A1 (es) Composiciones de corticosteroides de administracion oral
RU2007111713A (ru) Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию
JP2009502355A5 (enExample)
JP2013514837A5 (enExample)
BR112019020492A2 (pt) dispositivo de injeção e/ou infusão usável inteligente
JP2017504590A5 (enExample)
PT2659881T (pt) Formulação de fármaco de libertação retardada
AR083422A1 (es) Composiciones y metodos para tratar la hipertension pulmonar
PE20091574A1 (es) Sistema de administracion de drogas con efecto estabilizante
JP2007530540A5 (enExample)
JP2010520246A5 (enExample)
JP2011207873A5 (enExample)
AR102228A1 (es) Una formulación de metformina de liberación sostenida y un método de preparación de la misma
CR20150665A (es) Complemento de hierro
WO2014060952A1 (en) Osmotic floating tablets